2008 U.S. Psychiatric & Mental Health Congress Conference & Exhibition

in this activity, attendees will be able to: 1) Recognize the clinical signs of NMS associated with typical and atypical antipsychotics to help determine a diagnosis; 2) Identify related conditions and risk factors associated with the development of NMS; 3) Discuss the differential diagnosis and strategies for the treatment of NMS. 21-0 Insomnia 22-2 8:00-9:15 a.m. 21-1 Practice Management Series 1A: Workflow for Enhanced Productivity PI The progressive psychiatric practice wants to enhance productivity without compromising patient service. This presentation will explore ways to manage workflow, make the most of time, and improve productivity—all the while becoming more “patient-centered.” By participating in this activity, attendees will be able to: 1) Adopt a disciplined approach to time management in the medical office; 2) Evaluate simple processes to manage workflow in private psychiatric practice; and 3) Implement protocols that will allow improved productivity while enhancing psychiatric patient service. Pharmacotherapy of Dual-Diagnosis Patients AP RX 17-5 Should Side Effects Be the Determining Factor in Choosing an Antipsychotic? RX The choice of the right atypical antipsychotic for an individual patient can be a daunting challenge to most physicians. By participating in this activity, attendees will be able to: 1) Discuss side effects of first-and-second generation antipsychotics; 2) Identify side effect profiles among secondgeneration antipsychotics; and 3) Develop a treatment strategy that includes risk/benefit ratio as a determining factor in choice of antipsychotic. The prevalence of coexisting substance misuse and psychiatric disorder (dual diagnosis) has increased over the past decade, and indications are that it will continue to rise. By participating in this activity, the attendees will be able to: 1) Describe the relative risk of comorbid substance abuse with other psychiatric syndromes; 2) Identify the available pharmacological agents for treatment of dual-diagnosis patients and medication treatment for substance dependence disorders; and 3) Discuss the difficulties relating to the treatment and the harm reduction model versus the abstinence model for dual-diagnosis patients. 22-3 Risk Management: What Is It? PI 21-2 17-6 Psycho-Proctology: The Bottom Line RX HOT! Returning Veterans and Exposure to Depleted Uranium: An Update PD SC Constipation is a major side effect of many of the pharmacological agents used in psychiatry and is believed to be an anticholinergic side effect. By participating in this activity, attendees will be able to: 1) Discuss the consequences of undertreated, or unrecognized, severe psychiatric drugassociated constipation progressing to fatal bowel obstruction; 2) Recognize the possibilities such as altered sensitivity to pain and difficulty expressing the pain associated with certain psychiatric disorders (e.g., constipation in schizophrenia patients); and 3) Identify guidelines to recognize the symptoms of constipation in psychiatric patients. 17-7 PD PT Cognitive Therapy to Aid Adjustment to Cancer: Where It’s Going— A Preview Mental health clinicians are being increasingly challenged by patients who believe themselves to have been exposed to radiogenic materials. This session will identify common complaints both of indigenous peoples exposed to unrefined uranium and veterans of the wars in Iraq exposed to munitions laced with depleted uranium. Department of Defense publications and politicians claim there is no health risk to the use of depleted uranium or other radiogenic materials used in combat. By participating in this activity, attendees will be able to: 1) Determine what to do with the competing and contradictory fears of their patients on the one hand and claims of "official" reports on the other; 2) Review findings from the New Mexico Veterans Project that the state began in 2007, offering free testing to all resident veterans who believe they have been exposed; and 3) TBD In the healthcare environment, proactive risk management is essential and there is no specialty where this rings more true than psychiatry. By participating in this activity, attendees will be able to: 1) Describe what comprises the standard of care and what that term means in the legal sense; 2) Explain how practicing psychiatrists can ensure they are meeting or exceeding the standard of care; and 3) Discuss actual cases of poor risk management and how they could have been ameliorated. 23-0 23-1 Schizophrenia Happiness NP SC This course will consider different formats for a psychiatrist working in an oncology setting, leading to a focus on the role of a mental health clinician in a private oncology practice. Cognitive therapy approaches to problems adjusting to cancer at its various stages will be discussed.By participating in this activity, attendees will be able to: 1) Identify ways to succeed in mental health work in a medical setting alongside oncologists and their staff; 2) Describe the trajectories involved in cancer, and the patient’s needs at each stage; and 3) Express the suitability of cognitive therapy as a framework for helping a patient deal with issues raised by a diagnosis of cancer. 21-3 Neuropsychiatric Masquerades: Medical and Neurologic Disorders That Present With Psychiatric Symptoms NP Happiness is nothing but our emotional state of mind. The level of our inner happiness is a direct reflection of the thoughts we choose to run through our mind. By participating in this activity, attendees will be able to: 1) Recognize their fears, phobias, anger, resentment, jealousy and all types of emotional unhappiness by identifying each of their negative and addictive causes; 2) Discover more effective personal awareness of their happiness style along with the possibility of more rewarding choices within their lives and relationships; and 3) Discuss the recipes to increase their satisfaction and happiness in life. 17-8 Systems Neuropsychiatry, Part 2: The Decade of the Mind and the Future of Clinical Psychiatry NP The treatment of psychiatric disorders and the promotion and protection of mental health are pivotal to the upcoming 2010 – 2020 “Decade of the Mind” (see Systems Neuropsychiatry, Part 1: The Decade of the Mind), as are the notions of understanding, enriching, and modeling the mind. Consequences for clinical psychiatry of the ‘Decade of the Mind” are elaborated upon in the second of this two part seminar. By participating in this activity, attendees will be able to: 1) Describe how cognitive neuropsychiatry becomes the framework for psychiatry in a “Decade of the Mind”; 2) Identify the challenges and opportunities that this new paradigm offers psychiatric diagnosis, treatment planning, treatment and prevention; and 3) Express how “learning” a transdisciplinary approach, which characterizes best practice in the Decade of the Mind, is beneficial to practice. Psychiatric masquerades are medical and/or neurological conditions which present primarily with psychiatric or behavioral symptoms. The conditions included in this category range from neurological disorders (e.g. seizure disorders and MS), to infectious diseases (e.g. syphilis, herpes and HIV), to connective tissue disorders (e.g. vasculitis and SLE), to malignancies (e.g., paraneoplastic syndromes and pancreatic cancer), to metabolic disorders (e.g. wilson’s disease and prophyria), to various toxins and substances our patients may be exposed to. In this lecture, we will discuss the presentation and symptoms of the most common masquerades, focusing on pearls for timely diagnosis, and discuss potential management and treatment strategies. By participating in this activity, attendees will be able to: 1) Recognize the most common infectious disorders presenting with psychiatric symptoms; 2) Explain the incidence, epidemiology and clinical features of the most common neuropsychiatric disorders masquerading as psychiatric illness; 3) Recommend the research-based, effective treatment options for these conditions. 23-2 Alcohol Withdrawal Syndromes: Pathophysiology and Managementt AP 3:45-6:45 p.m. Exhibit Hall 7:00-9:00 p.m. 19-0 Major Depressive Disorder 9:30-10:45 a.m. 22-0 Adult ADHD 22-1 Practice Management Series 1B: Marketing in Private Practice: Smart Tips Inside and Outside the Psychiatric Office PI Marketing isn’t just about advertising, and advertising isn’t just about a full page in the phone book or 30 seconds on the radio. This presentation will help private practice psychiatrists fit the concept of marketing into their ideal of patient care. How-tos for both internal and external strategies, including staffing and training, are designed for real-world implementation and practice growth. By participating in this activity, attendees will be able to: 1) Develop effective strategies for increasing community recognition of a private psychiatric practice; 2)Enhance relationships with colleagues and other resources to ensure strong referral streams; and 3) Integrate staffing considerations into marketing decisions for improved patient service. Alcohol abuse is the most serious drug abuse problem in the U.S. A substantial percentage of patients presenting for treatment have alcohol related medical/neurological/psychiatric problems, many of which are associated to the presence of withdrawal syndromes. About 10% of hospitalized patients develop delirium tremens, which carries a mortality rate up to 15% when inappropriately treated. Each phase of alcohol withdrawal has its own rhythm which, if not understood, may lead to treatment errors and potentially devastating sequelae. In this lecture we will discuss the pathophysiological changes caused by alcohol dependence leading to tolerance and the development of withdrawal syndrome; review the literature regarding diagnosis and management; review the available tools to monitor alcohol withdrawal progression and treatment effectiveness; and discuss recent studies discussing tr http://discussed.By http://www.CMELLC.com/psychcongress

Table of Contents Feed for the Digital Edition of 2008 U.S. Psychiatric & Mental Health Congress Conference & Exhibition

Table of Contents Exhibit Hall Opportunities Industry-Supported Symposia Educational Tracks Comprehensive Sessions Congress Hosts Program Advisory Members Faculty Presenters About San Diego Discounted, Tax-Deductible Tuition Risk-Free Registration

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.